IGCS 2020 Final Program Book 9.10.20 IX
IGCS 2020 Final Program Book 9.10.20 IX
PROGRAM
CONTENTS
MEETING INFORMATION
Welcome Letter
General Information
Social Media #IGCS2020
CME/CPD Accreditation
Program at a Glance
Surgical Film Cinema
IGCS Business Meeting Agenda
Women4Women Concert
SCIENTIFIC PROGRAM
Thursday, September 10, 2020
Friday, September 11, 2020
Saturday, September 12, 2020
Sunday September 13, 2020
xDigital
powered by
WELCOME LETTER
Dear Colleagues:
On behalf of the Scientific Program Committee, we are pleased to bring you the 2020 IGCS Annual
Global Meeting utilizing the most innovative interactive “xDigital” technology platform designed to truly
immerse you into the meeting experience from the comfort of your home or office.
Despite the challenges of the pandemic, IGCS is committed to virtually provide our members and
delegates around the world with targeted educational programming, the latest scientific research in
gynecologic cancers, and interactive networking opportunities. The IGCS leadership, dedicated staff
and our new digital technology partner, iCrossing has risen to the occasion, making every effort to
transition the IGCS Meeting into an online environment to fulfil the mission of our society. We are
overwhelmed and grateful for the support of our course directors, expert faculty, abstract presenters,
and industry partners who have worked tirelessly to contribute to our program in an accelerated
timeline.
Following the tradition of previous meetings, IGCS 2020 will provide you with the opportunity to learn
about the latest clinical advances as well as international developments in research, practice, and
treatment for the care of women affected by gynecological cancer. Concurrent educational
programming will run on four channels at different times each day to ensure that our delegates in all
parts of the world are able to participate in parts of the program. Many of the live sessions with have
opportunities for audience participation through Q&A segments and polling.
In addition to the scheduled programming, we are thrilled to offer 24-hour access to the Meeting Portal
where delegates can access the Digital Exhibition Hall for the latest updates and technology from our
industry partners, the Surgical Film Cinema which contains 21 films, the Abstract Poster Hall with over
300 posters and nearly 50 audio files where the poster authors further explain their research and the
IGCS Link which allows delegates to send personal messages to each other.
The Meeting Portal will remain open 10 days after the meeting until September 24th, giving delegates
the opportunity to watch recordings of the educational sessions and to access all the other features
mentioned above.
Perhaps now more than ever, it is important for the gynecologic oncology community to utilize novel
virtual solutions to share research for the sake of caring for patients with gynecologic malignancies.
IGCS has always served to unite the globe in the fight against gynecologic cancers.
Sincerely,
igcsmeeting.com
GENERAL INFORMATION
Meeting Access
IGCS xDigital Meeting Delegates may access the Meeting Portal at www.2020.igcsmeeting.com
and login with the information provided via email. The email was sent from
[email protected] with the subject line “IMPORTANT: DELEGATE PASS – IGCS xDigital.”
If you cannot find your email, check your spam filter first. If you cannot locate the message, please
email [email protected].
Exhibition Times
The Digital Exhibition Hall will be open 24 hours throughout the duration of the Meeting starting on
September 10, 2020 at 14:00 UTC and ending on September 13, 2020 at 06:00 UTC. The Meeting
Portal will remain open for 10 days after the meeting (until September 24, 2020) and delegates
may continue to access the exhibit hall while the Meeting Portal is open.
Meeting Abstracts
All the Meeting abstracts are available to download at .igcsmeeting.com/program/
Digital Posters are accessible from the Abstract Poster Hall within the Meeting Portal.
The IGCS 2020 Meeting Abstracts will also be published in the International Journal of
Gynecological Cancer after the meeting.
Meeting Organizers
International Gynecologic Cancer Society and iCrossing, a Hearst Company
#IGCS2020
CONTINUING MEDICAL EDUCATION
EDUCATIONAL OBJECTIVES
• Address individual needs in compliance with their Continuous Professional Development (CPD) plan.
• Describe the latest information in treatment strategies in gynaecologic cancers.
• Identify educational resources, networks and other for exchange of knowledge and learning about gynaecological
cancer.
• Discuss translational research and clinical trials in gynecological cancers.
• Address novelties in surgery, radiotherapy, chemotherapy and immunotherapy in the treatment of gynecological
malignancies.
TARGET AUDIENCE IGCS 2020 is the global meeting place for clinical practitioners, researchers, clinical researchers in the
field of gynecological oncology and its sub-specialties.
INDUSTRY SUPPORT DISCLOSURE This event is supported, in part, by funding from industry. All support is managed in
strict accordance with CME/CPD accreditation criteria and standards for commercial support. Appropriate
acknowledgement of all supporting organizations is made in the program guide and on the event website
• A list of all industry supporters and sessions is available in the Recognition, Acknowledgements and Industry Support
section at the back of this program book.
• Detailed programs for all Industry Sessions are available on the Online Program
E ACCREDITATION The xDigital IGCS Annual Global Meeting has been accredited by the European Accreditation Council
for Continuing Medical Education (EACCME®) with: 12 European CME credits (ECMEC®s). Each medical specialist should
claim only those hours of credit that he/she actually spent in the educational activity.” Below the breakdown of ECMEC®s
per day:
September 10 - 3.00 September 11 - 3.00 September 12 - 3.00 September 13 - 3.00
AMERICAN MEDICAL ASSOCIATION (AMA) Through an agreement between the European Union of Medical Specialists and
the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA
Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at https://
edhub.ama-assn.org/pages/applications
ROYAL COLLEGE OF PHYSICIANS AND SURGEONS OF CANADA Live educational activities, occurring outside of Canada,
recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as
defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.
TO RECEIVE YOUR CME/CPD CERTIFICATE The CME/CPD certificate will be available after completing the online
evaluation and credit claiming procedure. The process takes about 10 minutes. We thank you for your feedback as it is an
important part of CME/CPD accreditation and helps improve future educational offerings.
1 CME
17:00—18:15
CHANNEL 1 LIVE CHANNEL 2
Industry Symposium Industry Symposium
Not included in main event CME/CPD Not included in main event CME/CPD
xDigital
powered by
Friday, September 11, 2020
Schedule at a Glance
Universal Coordinated Time (UTC)
13:00—
CHANNEL 2 LIVE
13:30
Tumor Board
Chairs: R. Wendel
Naumann (USA), Donal
13:30— Brennan (Ireland)
14:30
1 CME 1 CME
14:30—
CHANNEL 1 LIVE CHANNEL 2
16:00
Industry Symposium Industry Symposium
Not included in main event CME/CPD Not included in main event CME/CPD
17:00— CHANNEL 1
18:00
Women4Women Concert
xDigital
powered by
Saturday, September 12, 2020
Schedule at a Glance
14:30—
CHANNEL 2 CHANNEL 4
15:00
GTD: State of the Art An Update on the
15:00—
Management of High CHANNEL 3 WHO Classification of
15:30
-Risk, & Recurrent/ Meet the Technology Tumors of the Female
Refractory Disease Genital Tract
Chairs: John Soper (USA), Chair: Gian Franco
Neil Horowitz (USA) Zannoni (Italy)
2 CMEs 1 CME
2 CMEs 3 CMEs
1 CME
6:00—7:30
CHANNEL 1 LIVE
Regional Session: Korean Society of Gynecologic Oncology (KSGO)
Chairs: Seung-Cheol Kim, Jae-Weon Kim, Young-Tak Kim, Young-Tae Kim
7:30—9:00
CHANNEL 1 LIVE
Regional Session: Japanese Society of Gynecologic Cancer (JSGO)
Chairs: Fuminori Taniguchi, Daichi Maede, Ken Yamaguchi, Hiroaki Kajiyama, Noriomi Matsumura
xDigital
powered by
SURGICAL FILM CINEMA
Laparoscopic Management Of Huge Ovarian Cyst; Novel Technique
S. Addley, H. Soleymani Majd, M. Alazzam
xDigital
powered by
SURGICAL FILM CINEMA
Robotic Ileal Neovagina
R. Ribeiro, A. Munhóz, H.K. Rabelo, A. Vargas, A. Tsunoda, J. Linhares
xDigital
powered by
IGCS ANNUAL BUSINESS MEETING
Saturday, September 12, 2020
8:30 AM CDT USA | 1:30 PM UTC
Channel 1
Agenda
xDigital
powered by
WOMEN4WOMEN CONCERT
We are pleased to present the IGCS 2020 delegates with a special concert
featuring renowned European Performers.
Incanto di Venere
Music of the heart, rendered in an
original way, at times soft at times
passionate, by the Incanto di Venere:
the vocal interweaving of four eclectic
sopranos and the refined instrumental
fabric of strings and piano.
Set List:
Con te partirò | Habanera – Carmen |
Caruso | Once upon the time in
America | The Gladiator
Band of the Guardia di Finanza
Officially founded in 1926, the “Guardia
di Finanza” Musical Band is composed
by 102 musicians graduated from
outstanding Italian conservatoires and
selected amongst the best contestants.
Considered as one of the most
prestigious bands worldwide, the Band
of the “Guardia di Finanza” performed
under the guidance of well-known
Maestros, such as Zubin Metha and
Steven Mercurio. Since 2002, its
conductor is Colonel Maestro Leonardo
Laserra Ingrosso.
Set List:
Aida | Ennio Morricone Medley from
Western Movies | Nessun Dorma - xDigital
Turandot powered by
MEMBER BENEFITS
Professional Journal IGCS Annual Global Meeting
The International Journal of Gynecological Cancer Take advantage of discounted registration to attend
(IJGC) publishes original research, editorials, case the IGCS meeting held in different global regions.
studies, and more related to the treatment of Meeting participation is an excellent way to learn
gynecologic malignancies with a focus on about issues affecting the profession, meet experts in
international perspectives. Video articles and weekly the field, present your research, gain inspiration and
podcasts enhance the learning experience. participate in important initiatives.
Survivors and caregivers from all around the world will gather online for a 4-
hour Summit where gynecologic cancer experts, survivors, and advocates will
discuss the science, survivorship, and advocacy.
Registration is FREE.
Learn more about the summit and sign up today to reserve your virtual seat.
igcs.org/2020-virtual-advocacy-summit
2020 Annual Global Meeting
of the International Gynecologic
Cancer Society
SCIENTIFIC PROGRAM
IGCS 2020 SCIENTIFIC PROGRAM
14:00 WELCOME
Chairs: Thomas Herzog (USA), Rainer Kimmig (Germany)
IGCS President: Roberto Angioli (Italy)
14:30 Welcome
Nicoletta Colombo (Italy)
14:39 IGCS20_1255: Efficacy and Safety of Lenvatinib Plus Pembrolizumab in Patients with Previously Treated
Ovarian Cancer in the Multicohort Phase 2 LEAP-005 Study
A. González-Martín, H. Chung, E. Saada-Bouzid, E. Yanez, H. Senellart, P.A. Cassier, B. Basu, R. Ghori, P. Kubiak,
A. Smith, K. Norwood, Z. Lwin
14:47 IGCS20_1268: Postprogression Efficacy Outcomes From the Phase 3 ARIEL3 Study of Rucaparib in
Patients With Platinum-Sensitive Recurrent Ovarian Carcinoma Associated With Either BRCA1 or BRCA2
Mutations
J. Weberpals, A. Oza, D. Lorusso, G. Scambia, C. Aghajanian, A. Oaknin, A. Dean, N. Colombo, A.R. Clamp, A.
Leary, R.W. Holloway, M. Amenedo Gancedo, P.C. Fong, J.C. Goh, D.M. O’Malley, D.K. Armstrong, S. Banerjee, J.
García-Donas, E.M. Swisher, T. Cameron, L. Maloney, S. Goble, R.L. Coleman, J.A. Ledermann
14:54 Distillation
Kathleen Moore (USA)
xDigital
powered by
THURSDAY, SEPTEMBER 10
IGCS 2020 SCIENTIFIC PROGRAM
15:00 Welcome
Moderator 1: Matthew Powell (USA)
15:01 IGCS20_1447: Refining Pathologic Interpretation of Endometrial Carcinomas: Lessons Learned from a
Nationwide Study in a new Era of Molecular Classification
E. Thompson, J. Huvila, S. Leung, J. Irving, N. van der Westhuizen, M. Kinloch, A. Lytwyn, M. Sur, C. Parra-
Herran, A. Yasmeen, F. Gougeon, C. Morin, K. Grondin, S. Offman, T. Salisbury, E. He, J. Lawson, J. Vanden
Broek, C. Bell, K. Ennour-Idrissi, C. Wohlmuth, D. Vicus, D. Vicus, W. Gotlieb, L. Helpman, A. Lum, J. Senz, D.
Huntsman, B. Gilks, J.N. McAlpine
15:09 IGCS20_1251: Understanding the clinical implication of mismatch repair deficiency in endometrioid
endometrial cancer through a prospective study
S. Kim, A. Tone, A. Pollett, R. Kim, M. Cesari, B. Clarke, L. Eiriksson, T. Hart, S. Holter, A. Lytwyn, M. Maganti, L.
Oldfield, T. Pugh, S. Gallinger, M. Bernardini, A. Oza, V. Dube, J. Lerner-Ellis, E. Van de Laar, D. Vicus, S.
Ferguson
15:17 IGCS20_1049: Variation in practice in endometrial cancer (EC); can molecular classification direct care
and reduce costs associated with management?
E. Thompson, A. Lum, J. Huvila, S. Scott, V. Lui, E. He, T. Salisbury, S. Keane, S. Keane, V. Samouelian, J. Irving, S.
Salvador, L. Helpman, C. Wohlmuth, M. Kinloch, S. Offman, D. Vicus, K. Grondin, W. Gotlieb, M. Plante, D.
Huntsman, A. Talhouk, C.B. Gilks, G. Hanley, J. McAlpine
15:25 Distillation
Carien Creutzberg (The Netherlands)
15:30 IGCS20_1231: Sentinel lymph node biopsy versus lymphadenectomy for intermediate and high grade
endometrial cancer staging (SENTOR trial): A prospective multicenter cohort study
M. Cusimano, D. Vicus, K. Pulman, M. Q. Bernardini, G. Bouchard-Fortier, S. Laframboise, T. May, L. Hogen, A.
Covens, L.T. Gien, R. Kupets, M. Rouzbahman, B.A. Clarke, J. Mirkovic, M. Cesari, G. Turashvili, M. Maganti, A.
Zia, G.E.V. Ene, S. Ferguson
15:38 IGCS20_1246: A multicentric randomized trial to evaluate the ROle of uterine MANipulator on
laparoscopic/robotic HYsterectomy for the treatment of low-risk endometrial cancer: the ROMANHY
Trial (NCT:02762214)
S. Gueli Alletti, E. Perrone, C. Fedele, G. Vizzielli, A. Fagotti, V. Gallotta, C. Rossitto, B. Costantini, S. Restaino, G.
Monterossi, F. Fanfani, G. Scambia, S. Cianci, V. Chiantera, S. Uccella, A. Ercoli
15:46 IGCS20_1423: Frailty is Independently Associated with Worse Outcomes and Increased Resource Use
Following Procedures to Treat Endometrial Cancer
M. Nakhla, A. Mandelbaum, R. Salani, J. Cohen, P. Benharash
xDigital
powered by
THURSDAY, SEPTEMBER 10
IGCS 2020 SCIENTIFIC PROGRAM
16:00 Introduction
Moderator: Audrey Tsunoda (Brazil)
16:20 Rebuttal
Andreas DuBois (Germany)
16:38 Rebuttal
Robert Coleman (USA)
16:41 Comments
Audrey Tsunoda (Brazil)
INDUSTRY SYMPOSIA
Not included in main event CME/CPD. Please refer to the meeting portal interactive agenda for details.
17:00 – 18:15 UTC
INDUSTRY SYMPOSIA
Not included in main event CME/CPD. Please refer to the meeting portal interactive agenda for details.
xDigital
powered by
THURSDAY, SEPTEMBER 10
IGCS 2020 SCIENTIFIC PROGRAM
Welcome
Chairs: Mario Leitao (USA), Vance Broach (USA)
xDigital
powered by
THURSDAY, SEPTEMBER 10
IGCS 2020 SCIENTIFIC PROGRAM
INDUSTRY SYMPOSIUM
Not included in main event CME/CPD. Please refer to the meeting portal interactive agenda for details.
10:00 – 11:00 UTC
11:00 Welcome
Moderators: Paula Wimberger (Germany), Qinglei Gao (China)
11:01 IGCS20_1420: The learning curve of robot-assisted laparoscopy has impact on the oncological outcomes
of early stage cervical cancer patients
I. Baeten, J. Hoogendam, H. Schreuder, I. Jürgenliemk-Schulz, R. Verheijen, R. Zweemer, K. Gerestein
11:09 IGCS20_1039: Oncologic Outcomes and Role of Adjuvant Therapy in Endometrial Cancer Patients with
Low Volume Metastasis in the Sentinel Lymph Nodes: An International Multi-Institutional Study.
K. Ghoniem, G. Dinoi, A. Larish, X. Zhou, M. AlHilli, S. Wallace, C. Wohlmuth, G. Baiocchi, N. Tokgozoglu, F.
Raspagliesi, A. Buda, V. Zanagnolo, I. Zapardiel, N. Jagasia, R. Giuntoli, A. Glickman, M. Peiretti, M. Lanner, E.
Chacon, J. Di Guilmi, A. Pereira, E. Faron, A. Fishman, C. Nitschmann, S. Parker, A. Joehlin-Price, B. Lees, A.
Covens, L. De Brot, C. Taskiran, G. Bogani, C. Paniga, F. Multinu, A. Hernandez-Gutierrez, A. L. Weaver, M. E.
McGree
11:17 Distillation
Floor Backes (USA)
11:30 IGCS20_1440: Efficacy on Individualized Starting Dose (ISD) and Fixed Starting Dose (FSD) of Niraparib
per Investigator-Assessment (IA) in Newly Diagnosed Advanced Ovarian Cancer (OC)
W. Graybill, M. Mirza, A. González-Martin, D. O'Malley, L. Gaba, O.W.S. Yap, E. Guerra, P.G Rose, J. Baurain, S.
Ghamande, H. Denys, E. Prendergast, C. Pisano, P. Follana, E.I. Braicu, P.M. Calvert, J. Korach, Y. Li, D. Gupta,
B.J. Monk
11:38 Distillation
Asima Mukhopadhyay (India)
FRIDAY, SEPTEMBER 11
IGCS 2020 SCIENTIFIC PROGRAM
12:00 Welcome
Chairs: Robert Coleman (USA), Nicoletta Colombo (Italy), Douglas Levine (USA)
12:05 How to Subclassify Ovarian Carcinoma into Hystotypes & Molecular Subtypes?
Martin Koebel (Canada)
12:45 Discussion
13:25 Platinum Sensitive Recurrence at 12 Months: What’s next? Who Benefits from PARP in the Recurring
Setting?
Rosalind Glasspool (UK)
13:35 Discussion
14:05 Discussion
INDUSTRY SYMPOSIA
Not included in main event CME/CPD. Please refer to the meeting portal interactive agenda for details.
14:30 – 16:00 UTC
xDigital
powered by
FRIDAY, SEPTEMBER 11
IGCS 2020 SCIENTIFIC PROGRAM
INDUSTRY SYMPOSIA
Not included in main event CME/CPD. Please refer to the meeting portal interactive agenda for details.
16:00 – 17:00 UTC
WOMEN4WOMEN CONCERT
17:00 – 18:00 UTC
12:05 Pro
Willemien van Driel (The Netherlands)
12:20 Rebuttal
Christian Marth (Austria)
12:23 Con
Christian Marth (Austria)
12:38 Rebuttal
Willemien van Driel (The Netherlands)
12:41 Comments
Keiichi Fujiwara (Japan)
TUMOR BOARD
13:00 – 14:30 UTC
13:00 Welcome
R. Wendel Naumann (USA)
xDigital
powered by
FRIDAY, SEPTEMBER 11
IGCS 2020 SCIENTIFIC PROGRAM
13:14 Polling
13:15 Discussant
Isabelle Ray-Coquard (France)
13:30 Case 2
Donal Brennan (Ireland)
13:41 Polling
13:45 Discussant
Carien Creutzberg (The Netherlands)
13:53 Discussant
Matthew Powell (USA)
14:00 Case 3
R. Wendel Naumann (USA)
14:11 Polling
14;15 Discussant
Linda Mileshkin (Australia)
INDUSTRY SYMPOSIA
Not included in main event CME/CPD. Please refer to the meeting portal interactive agenda for details.
14:30 – 16:00 UTC
xDigital
powered by
FRIDAY, SEPTEMBER 11
IGCS 2020 SCIENTIFIC PROGRAM
Closing Comments
Thomas Ind (UK)
Chairs: Mila Salcedo (Brazil), Joseph Ng (Singapore), Kathleen Schmeler (USA), Ida Ismail-Pratt (Singapore)
xDigital
powered by
FRIDAY, SEPTEMBER 11
IGCS 2020 SCIENTIFIC PROGRAM
xDigital
powered by
FRIDAY, SEPTEMBER 11
IGCS 2020 SCIENTIFIC PROGRAM
Chairs: Michael Höckel (Germany), Benedetti Panici (Italy), Ate van der Zee (The Netherlands)
11:00 Current Insights in the Etiology & Pathogenesis of Vulvar Cancer: HPV Infection - Predisposing
Conditions - Premalignant Disease - Overt Malignancy
Joanne de Hullu (The Netherlands)
11:30 Debate: Early Stage Vulvar Cancer: An Overview of Current Standard of Surgical Care vs Cancer Field
Surgery for Vulvar Carcinoma as Alternative Approach
Maaike Oonk (The Netherlands) vs Nadja Dornhöfer (Germany)
PRESIDENTIAL PLENARY IV
12:30 – 13:30 UTC
12:45 World Ovarian Cancer Coalition Global Ovarian Cancer Charter Launch
Elisabeth Baugh (Canada), Frances Reid (UK)
12:52 Global Outreach & Engagement Initiatives of the International Gynecologic Cancer Society
Dicey Jackson Scroggins (USA)
Chairs: Pernille Jensen (Denmark), Andrea Mariani (USA), Matthew Powell (USA)
13:30 Sentinel LN is Positive on Frozen Section: Full Dissection vs "Why did I Send for Frozen?"
Edward Tanner (USA)
13:45 Sufficient Evidence to Implement SLN in Women with EC, High Risk Histology - Risk of Missing
Paraaortic LN Metastases
Emma Rossi (USA)
xDigital
powered by
SATURDAY, SEPTEMBER 12
IGCS 2020 SCIENTIFIC PROGRAM
14:05 What to do with ITC and Micro Metastasis in SLN on Final Pathology
Marie Plante (Canada)
14:17 No Need for Adjuvant Treatment or Send for the Chemo & Radiation? Or in the Middle?
Floor Backes (USA)
14:30 Debate: Molecular Profiling for Postop Risk Stratification & Adjuvant Treatment Decisions of Women with
Early Stage EC
Ready: Jessica McAlpine (Canada) vs Not Ready: Remi Nout (The Netherlands)
Panelist: Anuja Jhingran (USA)
15:00 Where are We Today & Where are We Going in the Treatment of Women with Advanced/Recurrent EC?
Mansoor Mirza (Denmark)
INDUSTRY SYMPOSIUM
Not included in main event CME/CPD. Please refer to the meeting portal interactive agenda for details.
15:30 – 16:30 UTC
SATURDAY, SEPTEMBER 12
IGCS 2020 SCIENTIFIC PROGRAM
GTD: STATE OF THE ART MANAGEMENT OF HIGH RISK, ULTRA-HIGH RISK, &
RECURRENT/REFRACTORY DISEASE
This session is presented in partnership with the International Society for the Study of Trophoblastic Disease (ISSTD).
14:30 – 15:30 UTC
SATURDAY, SEPTEMBER 12
IGCS 2020 SCIENTIFIC PROGRAM
INDUSTRY SYMPOSIUM
Not included in main event CME/CPD. Please refer to the meeting portal interactive agenda for details.
15:30 – 16:15 UTC
Overview
Christina Fotopoulou (UK)
How to Properly Perform the Fagotti Score in Diagnostic Laparoscopies Prior to Surgical Ovarian
Debulking
Anna Fagotti (Italy)
xDigital
powered by
SATURDAY, SEPTEMBER 12
IGCS 2020 SCIENTIFIC PROGRAM
Chairs: David Atallah (Lebanon), Muhieddine Seoud (Lebanon), Ali Ayhan (Turkey), Faruk Kose (Turkey)
xDigital
powered by
SATURDAY, SEPTEMBER 12
IGCS 2020 SCIENTIFIC PROGRAM
13:30 Welcome
Thomas Herzog (USA)
13:31 IGCS20_1018: Development of a triage tool including HE4, D-dimer, and fibrinogen for the assessment of
women presenting with pelvic masses
K. McKendry, S. Duff, S. O'Toole
13:36 IGCS20_1067: Molecular Subtype Diagnosis of Endometrial Carcinoma: Comparison of NGS Panel and
Promise Classifier
J. Huvila, K. Orte, P. Vainio, T. Mettälä, T. Joutsinimi, S. Hietanen
13:41 IGCS20_1226: Screening for cervical cancer in women under the age of 25: a cross-sectional study at an
University Hospital in Minas Gerais – Brazil
L. Barbosa, B. Napoleão, M. Franco, E. Ferreira-Filho, S. Nicolau
13:46 IGCS20_1486: Clinical management of gynecologic cancer patients during COVID-19 pandemia: the
experience of Day Hospital Tumori Femminili of Fondazione Policlinico Agostino Gemelli, IRCCS
E. Palluzzi, G. Corrado, G. Bolomini, L. Vertechy, C. Bottoni, E. Teodorico, C. Marchetti, M. Distefano, G. Scambia,
G. Ferrandina
13:51 IGCS20_1102: Prognostic Value and Association with Veliparib Benefit of Modeled CA-125 Elimination
Kinetics (KELIM) in Patients with Newly Diagnosed Ovarian Cancer: Analysis from the VELIA/GOG-3005
Study
B. You, G. Fleming, M. Bookman, K.N. Moore, K.D. Steffensen, R.L. Coleman
13:46 IGCS20_1165: Quantitative evaluation of lymph-vascular space invasion (LVSI) in patients affected by
endometrial cancer: prognostic and clinical implications
S. Restaino, L. Tortorella, E. Perrone, G. Monterossi, A. Gioè, I. Capasso, E. La Fera, G. Dinoi, G. Scambia, F.
Fanfani, G. Zannoni, V. Chiantera
xDigital
powered by
SATURDAY, SEPTEMBER 12
IGCS 2020 SCIENTIFIC PROGRAM
14:01 IGCS20_1184: A training program to build capacity for cervical cancer prevention in Mozambique
M. Salcedo, M. Varon, E. Baker, N. Osman, E. David, R. Rangeiro, D. Changule, V. Andrade, C.M. Oliveira, A.
Neves, J. Carns, C. Lorenzoni, K.M. Schmeler
14:06 IGCS20_1063: Development of a nomogram to predict interval debulking surgery feasibility when
primary cytoreduction is not an option.
A. Rosati, C. Marchetti, F. DeFelice, V. Tranquillo, V. Iacobelli, L. Quagliozzi, V. Salutari, G. Scambia, A. Fagotti
14:11 IGCS20_1007: Integrated model of patient factors, resectability score and surgical complexity index to
predict surgical outcome in debulking surgery for advanced ovarian cancer
L. Hogen, S. LAFRAMBOISE, T. May, A. Ding, M. Bernardini
14:16 IGCS20_1214: Increase in Uterine Serous Carcinoma: Will it Surpass Uterine Endometrioid Cancer? A
population analysis of 720,984 uterine cancer patients.
C. Liao, K. Tran, M. Richardson, K. Darcy, C. Tiao, C.A. Hamilton, L. Maxwell, A. Mann, D.S. Kapp, J. Chan
14:21 IGCS20_1450: Clinicopathologic Predictors Of Early Relapse In Advanced Epithelial Ovarian Cancer;
Development Of Prediction Models Using Nationwide Data
S. Said, R. Bretveld, H. Koffijberg, G. Sonke, R.F.P.M. Kruitwagen, J.A. de Hullu, A.M. van Altena, S. Siesling, M.A.
van der Aa
An Update on The WHO Classification of Tumors of The Female Genital Tract: Endocervical
Adenocarcinoma
Xavier Matias-Guru (Spain)
xDigital
powered by
SATURDAY, SEPTEMBER 12
IGCS 2020 SCIENTIFIC PROGRAM
2:00 Introduction
Rainer Kimmig (Germany)
Chairs: Bradley Monk (USA), Mary McCormack (UK), Ana Oaknin (Spain)
3:00 Introduction
3:20 Staging
Jalid Sehouli (Germany)
xDigital
powered by
SUNDAY, SEPTEMBER 13
IGCS 2020 SCIENTIFIC PROGRAM
4:35 Clinical Care in Under-Resourced Settings & How To Start A Clinical Trials Program
Marie Plante (Canada)
4:50 Discussion
5:00 Welcome
Moderators: David Atallah (Lebanon), Andreas Obermair (Australia)
5:01 IGCS20_1271: Phase II trial evaluating efficacy and safety of standard of care with or without
bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer
N. Nishikawa, T. Shoji, T. Enomoto, M. Abe, A. Okamoto, T. Saito, T. Oishi, S. Nagase, M. Mori, Y. Inokuchi, S.K.
Kamiura, T. Sugiyama
5:09 IGCS20_1306: Randomized Double-Blind Placebo Controlled Trial of Frontline Maintenance Vigil
Immunotherapy (VITAL study) in Stage III/IV Ovarian Cancer: Efficacy Assessment in BRCA1/2-wt
Patients
R. Rocconi, E. Grosen, S. Ghamande, J. Chan, M. Barve, J. Oh, D. Tewari, P. Morris, E. Stevens, J. Bottsford-Miller,
M. Tang, P. Aaron, G. Wallraven, E. Bognar, L. Manning, J. Nemunaitis, B. Slomovitz, T. Herzog, B. Monk, R.
Coleman
5:25 Distillation
5:30 IGCS20_1131: Safety and patient-reported outcomes in patients receiving niraparib in the
PRIMA/ENGOT-OV26/GOG-3012 trial
G. Freyer, B. Pothuri, S. Han, D. Chase, B. Monk, F. Heitz, R. Burger, L. Gaba, L. Van Le, E. Guerra, D. Bender, J.
Korach, N. Cloven, C. Churruca, P. Follana, P. DiSilvestro, J.F. Baurain, K. Jardon, C. Pisano, U. Peen, J.
Maenpaa, P. Hoskins, E. Bacque, Y. Li, L. Eliason, A. González-Martín
5:38 IGCS20_1207: Efficacy of maintenance olaparib plus bevacizumab by biomarker status in clinical higher-
and lower-risk patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1 trial
P. Harter, D. Petran, G. Scambia, E. Ortega, I. Tsibulak, S. Nagao, I. Vergote, J. Meunier, F. Priou, R. Sverdlin, T.
Milenkova, I. Ray-Coquard
SUNDAY, SEPTEMBER 13
IGCS 2020 SCIENTIFIC PROGRAM
2:00 Welcome
Moderators: Jessica McAlpine (Canada), David Tan (Singapore), Alexey Shevchuk (Russia), Shailesh
Puntambekar (India)
2:01 IGS20_1248: Overall Survival After Surgical Staging by Lymph Node Dissection Versus Sentinel Lymph
Node Biopsy In Endometrial Cancer: A National Cancer Database study.
S. Garzon, A. Mariani, C. Day, E. B. Habermann, C.L. Langstraat, G.E. Glaser, A. Kumar, A. Larish
2:13 IGCS20_1170: Can conisation specimens predict sentinel lymph node status in early-stage cervical
cancer? A SENTICOL group study
J. Mereaux, V. Balaya, B. Guani, L. Magaud, H. Bonsang-Kitzis, C. Ngo, F. Lecuru, P. Mathevet
2:29 IGCS20_1222: COVID-19: A review of the impact of the pandemic on ovarian cancer patient advocacy
organizations from around the world
F. Reid, C. MacKay
xDigital
powered by
SUNDAY, SEPTEMBER 13
IGCS 2020 SCIENTIFIC PROGRAM
3:09 IGCS20_1254: Therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage
epithelial ovarian cancer.
N. Bizzarri, A. Du Bois, R. Fruscio, F. De Felice, P. De Iaco, J. Casarin, E. Vizza, V. Chiantera, G. Corrado, S. Cianci,
P. Harter, B. Ataseven, M. Bommert, A.M Perrone, S. Magni, D. Ferrari, B. Zambetti, G. Scambia, A. Fagotti
3:26 IGCS20_1319: Prevalence and prognosis of Lynch syndrome and sporadic mismatch repair deficiency in
the combined PORTEC-1,-2 and -3 endometrial cancer trials
C. Post, E. Stelloo, V. Smit, D. Ruano, C.M. Tops, L. Vermij, T.A. Rutten, I.M. Jürgenliemk-Schulz, L.C. Lutgens, J.J.
Jobsen, R.A. Nout, E.J. Crosbie, M.E. Powell, L. Mileshkin, A. Leary, P. Bessette, S.M. de Boer, N. Horeweg, T. van
Wezel, T. Bosse, C.L Creutzberg
3:38 IGCS20_1189: Risk Factors Associated with Increasing Incidence of Uterine Cancer After Correcting for
Hysterectomy
C. Liao, K. Tran, M. Richardson, K. Darcy, C. Tian, C.A. Hamilton, L. Maxwell, A. Mann, D.S. Kapp, J.K. Chan
3:44 IGCS20_1179: Survival outcomes in endometrial cancer patients having lymphadenectomy, sentinel node
mapping followed by lymphadectomy and sentinel node mapping alone: long-term results of a
propensity-matched analysis
G. Bogani, C. Pinelli, A. Ditto, J. Casarin, F. Ghezzi, F. Raspagliesi
xDigital
powered by
SUNDAY, SEPTEMBER 13
IGCS 2020 SCIENTIFIC PROGRAM
Simple Trachelectomy as a Fertility-Sparing Treatment for Low Volume Early-Stage Cervical Cancer
Allan Covens (Canada)
Closing Comments
Chairs: Seung-Cheol Kim, Jae-Weon Kim, Young-Tak Kim, Young Tae Kim
6:30 Discussion
David Tan (Singapore)
6:55 Discussion
Ji Won Park (Rep. of Korea)
xDigital
powered by
SUNDAY, SEPTEMBER 13
IGCS 2020 SCIENTIFIC PROGRAM
7:15 Discussion
Jin Li (China)
7:30 Why in Japan? The high incidence of OCCC: A large cohort study
Fuminori Taniguchi (Japan)
xDigital
powered by
SUNDAY, SEPTEMBER 13
2020 Annual Global Meeting
of the International Gynecologic
Cancer Society
RECOGNITION,
ACKNOWLEDGEMENTS, AND
INDUSTRY SUPPORT
INDUSTRY SPONSORS
The Organizing Committee of IGCS 2020 would like to express its gratitude and acknowledge
the following companies and organizations for their generous support. More information about
the sponsors can be found within the Meeting Portal.
Sponsor
INDUSTRY SUPPORTED SESSIONS
Redefining expectations in the era of AstraZeneca Sept. 10, 2020 17:00—18:15 UTC 1
personalised medicine: maintenance
therapy in newly diagnosed ovarian
cancer.
Monitoring & Managing Adverse Merck Sept. 10, 2020 17:00—18:00 UTC 2
Reactions in the Treatment of
Certain Endometrial Carcinomas
Medmal Insurance: Risk & Safety Ania Foundation Sept. 11, 2020 10:00—11:00 UTC 1
The Role of tumor treatment fields in NovoCure Sept. 11, 2020 14:30—16:00 UTC 1
the management of recurrent
ovarian cancer
PARP Inhibitors in the maintenance GlaxoSmithKline Sept. 11, 2020 14:30—16:00 UTC 2
treatment of advanced ovarian
cancer: shared decision making,
patient perspectives
Perspectives on the place of da Intuitive Surgical Sept. 11, 2020 16:00—17:00 UTC 1
Vinci robotic assisted surgery in the
surgical management of
endometrial cancer patients
Missed opportunities for genetic Myriad Sept. 12, 2020 15:30—16:30 UTC 2
testing globally and potential
solutions to help patients with
gynecologic cancer
xDigital
powered by
STRATEGIC ALLIANCE PARTNERS
Africa
South African Society of Gynecologic Oncology
Through the IGCS Strategic
Latin America Alliance Partnership,
Argentinian Association of Gynecologic Oncology regional groups and
Colombian Association of Gynecologic Oncology societies strengthen their
Chilean Society of Gynecologic Oncology voice in the global arena
Peruvian Society of Gynecological Oncology and participate in strategic
The National Institute of Neoplastic Diseases (Peru) conversations with the IGCS
Mexican College of Gynecologic Oncologists leadership and other key
global leaders.
Eastern Europe
Belarusian Society of Oncologists (Gyn Onc Branch)
Russian Society of Oncologists in Cancer of Reproductive Systems
Eastern Asia
Chinese Gynecologic Cancer Society
Central Asia
Association of Oncologists of the Republic of Kazakhstan
Association of Oncologists of Uzbekistan
Kyrgyzstan
Tajikistan
Middle East
Israeli Society of Gynecological Oncology
Middle East and Mediterranean Association of Gynecologic Oncologists
Pan-Arabian Research Society of Gynecologic Oncology
xDigital
International powered by
The International Society of Gynecological Pathologists
ORGANIZATIONAL PARTNERS
xDigital
powered by
2020-2022 Council
OFFICERS
President Secretary-treasurer
Dr. Robert Coleman Dr. Anuja Jhingran
Gynecologic Oncologist Radiation Oncologist
Houston, TX, USA Houston, TX, USA
President Elect Secretary-Treasurer Elect
Dr. Keiichi Fujiwara Dr. Rainer Kimmig
Gynecologic Oncologist Gynecologic Oncologist
Saitama, Japan Essen, Germany
Vice President Immediate Past President
Dr. Jae-Weon Kim Dr. Roberto Angioli
Gynecologic Oncologist Gynecologic Oncologist
Seoul, Rep. of Korea Rome, Italy
COUNCIL MEMBERS
Dr. Greta Dreyer Dr. Daniela Luvero EX-OFFICIO COUNCIL MEMBERS
Gynecologic Oncologist Gynecologic Oncologist Mentorship & Training Committee Chair
Arcadia, Pretoria, South Africa Rome, Italy Dr. Kathleen Schmeler
Dr. Rhonda Farrell Dr. Joseph Soon-Yau Ng Gynecologic Oncologist
Gynecologic Oncologist Gynecologic Oncologist Houston, TX, USA
Sydney, Australia Singapore Education Committee Chair
Dr. Blake Gilks Dr. Rene Pareja Dr. Ritu Salani
Pathologist Gynecologic Oncologist Gynecologic Oncologist
Vancouver, BC, Canada Medellín, Colombia Columbus, OH
Chief Executive Officer
Dr. Rosalind Glasspool Dr. Alexandra Taylor
Mary Eiken
Medical Oncologist Radiation Oncologist
IGCS CEO
Glasgow, Scotland, UK London, England, UK
Chicago, IL
Dr. Mario Leitao, Jr.
Gynecologic Oncologist
New York, NY, USA
We gratefully acknowledge the Officers & Council Members who are ending their terms in 2020.
Monica Bacon, RN
Queen's University
Ontario, Canada
For her lifelong dedication to women’s health and serving the
gynecologic cancer community though nursing, clinical trial
coordination and international team building, advocacy, and
volunteerism.
ocrahope.org
2020 IJGC AWARD RECIPIENTS
Gloria Salvo, MD
University of Texas, MD Anderson Cancer
Center
Houston, TX, USA
Membership Manager Mentorship & Training Program Manager Online Education Manager
Cathy Fearing Susan Ralph Mandy Hansen
[email protected] [email protected] [email protected]
xDigital
powered by